Novavax
NVAX
#5101
Rank
S$2.27 B
Marketcap
S$13.79
Share price
10.22%
Change (1 day)
49.08%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2023 (TTM): S-$9.80

According to Novavax's latest financial reports the company's current EPS (TTM) is S-$1.94. In 2022 the company made an earnings per share (EPS) of S-$10.62 an increase over its 2021 EPS that were of S-$29.80.

EPS history for Novavax from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$9.80-7.73%
2022S-$10.62-64.36%
2021S-$29.80243%
2020S-$8.6919.75%
2019S-$7.25-43.86%
2018S-$12.92-19.84%
2017S-$16.12-38.83%
2016S-$26.3674.58%
2015S-$15.1063.89%
2014S-$9.2116.13%
2013S-$7.9340.91%
2012S-$5.6329.41%
2011S-$4.35-50%
2010S-$8.70-27.66%
2009S-$12.03-11.32%
2008S-$13.56-7.02%
2007S-$14.5946.15%
2006S-$9.9850%
2005S-$6.65-63.38%
2004S-$18.1720.34%
2003S-$15.10-35.87%
2002S-$23.54113.95%
2001S-$11.00-33.85%
2000S-$16.63109.68%
1999S-$7.93-40.38%
1998S-$13.3130%
1997S-$10.24-9.007199254741E+17%
1996S$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$6.72-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.55-539.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$3.68-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S-$3.37 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.57 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$2.58-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S-$0.56-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S-$1.84-5.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.40 126.32%๐Ÿ‡บ๐Ÿ‡ธ USA